Cargando…
Golden beam data provided by linear accelerator manufacturers should be used in the commissioning of treatment planning systems
Autores principales: | Yousif, Yousif A. M., Gastaldo, Jerome, Baldock, Clive |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125535/ https://www.ncbi.nlm.nih.gov/pubmed/35604544 http://dx.doi.org/10.1007/s13246-022-01134-2 |
Ejemplares similares
-
The post-COVID future of research conferences should be virtual
por: Schreiner, L. John, et al.
Publicado: (2022) -
Should ACPSEM develop its own position papers or just adopt those of the AAPM?
por: Kron, Tomas, et al.
Publicado: (2020) -
In the future simulations will replace clinical trials
por: Ebert, Martin A., et al.
Publicado: (2021) -
Mass drug administration should be implemented as a tool to accelerate elimination: against
por: Mendis, Kamini
Publicado: (2019) -
Operational consistency of medical linear accelerators manufactured and commissioned in series
por: Nguyen, Callistus M., et al.
Publicado: (2018)